Noble Financial Has Bullish Forecast for MariMed Q3 Earnings

MariMed Inc. (OTCMKTS:MRMD) – Equities research analysts at Noble Financial raised their Q3 2025 EPS estimates for shares of MariMed in a report released on Tuesday, August 12th. Noble Financial analyst J. Gomes now expects that the company will post earnings per share of $0.00 for the quarter, up from their prior forecast of ($0.01). Noble Financial also issued estimates for MariMed’s Q4 2025 earnings at $0.00 EPS, FY2025 earnings at ($0.02) EPS and FY2026 earnings at $0.00 EPS.

MariMed Stock Performance

Shares of OTCMKTS:MRMD opened at $0.13 on Thursday. The company has a market capitalization of $50.76 million, a price-to-earnings ratio of -4.33 and a beta of 3.02. The firm’s 50 day simple moving average is $0.09 and its 200 day simple moving average is $0.10. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.12 and a quick ratio of 0.37. MariMed has a fifty-two week low of $0.07 and a fifty-two week high of $0.29.

MariMed Company Profile

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.